Intestinal stem cells - types and markers

Cell Biology International

Volumn 37, Issue 5, 2013, Pages 406-414

  Zhang, Zhigang ^a   Huang, Jian ^a,b  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Active intestinal stem cells (A ISCs); Bmi1; Colorectal cancer; Intestinal stem cells (ISCs); Lgr5; Quiescent intestinal stem cells (Q ISCs)

Indexed keywords

B LYMPHOMA MO MLV INSERTION REGION 1; CELL MARKER; LEUCINE RICH REPEAT CONTAINING G PROTEIN COUPLED RECEPTOR 5; LEUCINE RICH REPEATS AND IMMUNOGLOBULIN LIKE DOMAIN 1; PLECKSTRIN HOMOLOGYLIKE DOMAIN PROTEIN; UNCLASSIFIED DRUG;

ACTIVE STEM CELL; BIOLOGICAL FUNCTIONS; CANCER STEM CELL; CELL FUNCTION; CELL POPULATION; CELL TYPE; CELLULAR DISTRIBUTION; COLORECTAL CANCER; INTESTINE; NONHUMAN; QUIESCENT STEM CELL; REGULATORY MECHANISM; REVIEW; STEM CELL; STEM CELL NICHE;

EID: 84878139409     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10049     Document Type: Review

References (90)

1. Abdel-Samad R, Zalzali H, Rammah C, Giraud J, Naudin C, Dupasquier S, Poulat F, Boizet-Bonhoure B, Lumbroso S, Mouzat K, Bonnans C, Pignodel C, Raynaud P, Fort P, Quittau-Prevostel C, Blache P (2011) MiniSOX9, a dominantnegative variant in colon cancer cells. Oncogene 30: 2493-503.
2. Albrecht I, Niesner U, Janke M, Menning A, Loddenkemper C, Kuhl AA, Lepenies I, Lexberg MH, Westendorf K, Hradilkova K, Grun J, Hamann A, Epstein JA, Chang HD, Tokoyoda K, Radbruch A (2010) Persistence of effector memory Th1 cells is regulated by Hopx. Eur J Immunol 40: 2993-3006.
3. BarkerN, van de Wetering M, Clevers H (2008) The intestinal stem cell. Genes Dev 22: 1856-64.
4. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003-7.
5. Bastide P, Darido C, Pannequin J, Kist R, Robine S, Marty-Double C, Bibeau F, Scherer G, Joubert D, Hollande F, Blache P, Jay P (2007) Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium. J Cell Biol 178: 635-48.
6. Boman BM, Fields JZ, Cavanaugh KL, Guetter A, Runquist OA (2008) How dysregulated colonic crypt dynamics cause stem cell overpopulation and initiate colon cancer. Cancer Res 68: 3304-13.
7. Boman BM,Wicha MS, Fields JZ, Runquist OA (2007) Symmetric division of cancer stem cells - a key mechanism in tumor growth that should be targeted in future therapeutic approaches. Clin Pharmacol Ther 81: 893-8.
8. Brabletz S, SchmalhoferO, Brabletz T (2009) Gastrointestinal stem cells in development and cancer. J Pathol 217: 307-17.
9. Buczacki S, Davies RJ, Winton DJ (2011) Stem cells, quiescence and rectal carcinoma: an unexplored relationship and potential therapeutic target. Br J Cancer 105: 1253-9.
10. Cabarcas SM, Mathews LA, Farrar WL (2011) The cancer stem cell niche - there goes the neighborhood? Int J Cancer 129: 2315-27
11. Carlone DL, Breault DT (2011) Slowly cycling versus rapidly cycling intestinal stem cells: distinct roles or redundancy. Cell Cycle 10: 723-4.
12. Carlone DL, Breault DT (2012) Tales from the crypt: the expanding role of slow cycling intestinal stem cells. Cell Stem Cell 10: 2-4.
13. Chaffer CL, Brueckmann I, Scheel C Kaestli AJ, Wiggins PA, Rodrigues LO, Brooks M, Reinhardt F, Su Y, Polyak K, Arendt LM, Kuperwasser C, Bierie B,Weinberg RA (2010) Normal and neoplastic nonstem cells can spontaneously convert to a stemlike state. Proc Natl Acad Sci USA 108: 7950-5.
14. Dalerba P, Cho RW, Clarke MF (2007) Cancer stem cells: models and concepts. Annu Rev Med 58: 267-84.
15. Daniel M, Peek GW, Tollefsbol TO (2012) Regulation of the human catalytic subunit of telomerase (hTERT). Gene 498: 135-46.
16. de LauW, Barker N, Low TY, Koo BK, Li VS, Teunissen H, Kujala P, Haegebarth A, Peters PJ, van de Wetering M, Stange DE, van Es JE, Guardavaccaro D, Schasfoort RB, Mohri Y, Nishimori K, Mohammed S, Heck AJ, Clevers H (2011) Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476: 293-7.
17. Durand A, Donahue B, Peignon G, Letourneur F, Cagnard N, Slomianny C, Perret C, Shroyer NF, Romagnolo B (2012) Functional intestinal stem cells after Paneth cell ablation induced by the loss of transcription factor Math1 (Atoh1). Proc Natl Acad Sci USA 109: 8965-70.
18. Edgar BA (2012) Intestinal stem cells: no longer immortal but ever so clever. EMBO J 31: 2441-3.
19. Fre S, Hannezo E, Sale S, Huyghe M, Lafkas D, Kissel H, Louvi A, Greve J, LouvardD, Artavanis-Tsakonas S (2011) Notch lineages and activity in intestinal stem cells determined by a new set of knock-in mice. PLoS ONE 6: e2578594.
20. Fuchs E (2009) The tortoise and the hair: slow-cycling cells in the stem cell race. Cell 137: 811-9.
21. Gerbe F, Brulin B, Makrini L, Legraverend C, Jay P (2009) DCAMKL-1 expression identifies Tuft cells rather than stem cells in the adult mouse intestinal epithelium. Gastroenterology 137: 2179-80; author reply 2180-1.
22. Geserick C, Tejera A, González-Suárez E, Klatt P, Blasco MA (2006) Expression of mTert in primary murine cells links the growthpromoting effects of telomerase to transforming growth factorb signaling. Oncogene 25: 4310-9.
23. Hawiger D, Wan YY, Eynon EE, Flavell RA (2010) The transcription cofactor Hopx is required for regulatory T cell function in dendritic cell-mediated peripheral T cell unresponsiveness. Nat Immunol 11: 962-8.
24. Hochegger K, Koppelstaetter C, Tagwerker A, Huber JM, Heininger D, Mayer G, Rosenkranz AR (2007) p21 and mTERT are novel markers for determining different ischemic time periods in renal. Am J Physiol Renal Physiol 292: F762-8.
25. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, Fields JZ, Wicha MS, Boman BM (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69: 3382-9.
26. Huang MY, Wang HM, Chang HJ, Hsiao CP, Wang JY, Lin SR (2012) Overexpression of S100B, TM4SF4, and OLFM4 genes is correlated with liver metastasis in Taiwanese colorectal cancer patients. DNA Cell Biol 31: 43-9.
27. Jensen KB, Watt FM (2006) Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence. Proc Natl Acad Sci USA 103: 11958-63.
28. Johnson EO, Chang KH, de Pablo Y, Ghosh S, Mehta R, Badve S, Shah K (2011) PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer. J Cell Sci 124: 2711-22.
29. Jung P, Sato T,Merlos-Suarez A, Barriga FM, Iglesias M, Rossell D, Auer H, Gallardo M, Blasco MA, Sancho E, Clevers H, Batlle E (2011) Isolation and in vitro expansion of human colonic stem cells. Nat Med 17: 1225-7.
30. Kayahara T, Sawada M, Takaishi S, Fukui H, Seno H, Fukuzawa H, Suzuki K, Hiai H, Kageyama R, Okano H, Chiba T (2003) Candidate markers for stem and early progenitor cells,Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Lett 535: 131-5.
31. Kleist B, Xu L, Li G, Kersten C (2011) Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer. Int J Clin Exp Pathol 4: 327-35.
32. Lee JS, Bae GY, Lee MO, Cha HJ (2012) Oncogenic challenges in stem cells and the link to cancer initiation. Arch Pharm Res 35: 235-44.
33. Levin TG, Powell AE, Davies PS, Silk AD, Dismuke AD, Anderson EC, Swain JR, Wong MH (2010) Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract. Gastroenterology 139: 2072- 2082.e5.
34. Li L Clevers H (2010) Coexistence of quiescent and active adult stem cells in mammals. Science 327: 542-5.
35. Liu RH, Yang MH, Xiang H, Bao LM, Yang HA, Yue LW, Jiang X, Ang N, Wu LY, Huang Y (2012) Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells. J Biomed Sci 19: 38.
36. Ljuslinder I, Golovleva I, Palmqvist R, Oberg A, Stenling R, Jonsson Y, Hedman H, Henriksson R, Malmer B (2007) LRIG1 expression in colorectal cancer. Acta Oncol 46: 1118-22.
37. Lu X, Lin F, Fang H, Yang X, Qin L (2011) Expression of a putative stem cell marker Musashi-1 in endometrium. Histol Histopathol 26: 1127-33.
38. Luo Z, Zhang Q, Zhao Z, Li B, Chen J, Wang Y (2011) OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer. J Cancer Res Clin Oncol 137: 1713-20.
39. May R, Riehl TE, Hunt C, Sureban SM, Anant S, Houchen CW (2008) Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells 26: 630-7.
40. May R, Sureban SM, Hoang N, Riehl TE, Lightfoot SA, Ramanujam R, Wyche JH, Anant S, Houchen CW (2009) Doublecortin and CaM kinase-like-1 and leucine-rich-repeatcontaining G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively. Stem Cells 27: 2571-9.
41. Medema JP, Vermeulen L (2011) Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 474: 318-26.
42. Mills JC, Gordon JI (2001) The intestinal stem cell niche: there grows the neighborhood. Proc Natl Acad Sci USA 98: 12334-6.
43. Montgomery RK, Carlone DL, Richmond CA, Farilla L, Kranendonk ME, Henderson DE, Baffour-Awuah NY, Ambruzs DM, Fogli LK, Algra S, Breault DT (2011) Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc Natl Acad Sci USA 108: 179-84.
44. Munoz J, Stange DE, Schepers AG, van de Wetering M, Koo BK, Itzkovitz S, Volckmann R, Kung KS, Koster J, Radulescu S, Myant K, Versteeg R, Sansom OJ, van Es JH, Barker N, van Oudenaarden A,Mohammed S, Heck AJ, Clevers H (2012) The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '{thorn}4' cell markers. EMBO J 31: 3079-91.
45. Murayama M, Okamoto R, Tsuchiya K, Akiyama J, Nakamura T, Sakamoto N, Kanai T, Watanabe M (2009) Musashi-1 suppresses expression of Paneth cell-specific genes in human intestinal epithelial cells. J Gastroenterol 44: 173-82.
46. Mwangi SM, Srinivasan S (2010) DCAMKL-1: a new horizon for pancreatic progenitor identification. Am J Physiol Gastrointest Liver Physiol 299: G301-2.
47. Neal MD, Richardson WM, Sodhi CP, Russo A, Hackam DJ (2011) Intestinal stem cells and their roles during mucosal injury and repair. J Surg Res 167: 1-8.
48. Neef R, Kuske MA, Pröls E, Johnson JP (2002) Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation. Cancer Res 62: 5920-9.
49. Nq A, Barker N (2011) Stem cells in epithelial renewal and cancer of the intestine. Eur Gastroenterol Hepatol Rev 7: 154-9.
50. Papailiou J, Bramis KJ, Gazouli M, Theodoropoulos G (2011) Stem cells in colon cancer. A new era in cancer theory begins. Int J Colorectal Dis 26: 1-11.
51. Powell AE, Wang Y, Li Y, Poulin EJ, Means AL, Washington MK, Higginbotham JN, Juchheim A, Prasad N, Levy SE, Guo Y, Shyr Y, Aronow BJ, Haigis KM, Franklin JL, Coffey RJ (2012) The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 149: 146-58.
52. Ramalingam S, Daughtridge GW, Johnston MJ, Gracz AD, Magness ST (2012) Distinct levels of Sox9 expression mark colon epithelial stem cells that form colonoids in culture. Am J Physiol Gastrointest Liver Physiol 302: G10-20.
53. Reed KR, Tunster SJ, Young M, Carrico A, John RM, Clarke AR (2011) Entopic overexpression of Ascl2 does not accelerate tumourigenesis in ApcMin mice. Gut 61: 1435-8.
54. Rezza A, Skah S, Roche C, Nadjar J, Samarut J, Plateroti M (2010) The overexpression of the putative gut stem cell marker Musashi-1 induces tumorigenesis through Wnt and Notch activation. J Cell Sci 123.
55. Sakthianandeswaren A, Christie M, D'Andreti C, Tsui C, Jorissen RN, Li S, Fleming NI, Gibbs P, Lipton L, Malaterre J, Ramsay RG, Phesse TJ, Ernst M, Jeffery RE, Poulsom R, Leedham SJ, Segditsas S, Tomlinson IP, Bernhard OK, Simpson RJ,Walker F, Faux MC, Church N, Catimel B, Flanagan DJ, Vincan E, Sieber OM (2011) PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis. Cancer Res 71: 3709-19.
56. Sangiorgi E, Capecchi MR (2008) Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 40: 915-20.
57. Sangiorgi E, Capecchi MR (2009) Bmi1 lineage tracing identifies a self-renewing pancreatic acinar cell subpopulation capable of maintaining pancreatic organ homeostasis. Proc Natl Acad Sci USA 106: 7101-6.
58. Schepers AG, Vries R, van den Born M, van de Wetering M, Clevers H (2011) Lgr5 intestinal stem cells have high telomerase activity and randomly segregate their chromosomes. EMBO J 30: 1104-9.
59. Scoville DH, Sato T, He XC, Li L (2008) Current view: intestinal stem cells and signaling. Gastroenterology 134: 849-64.
60. Sellheyer K, Krahl D (2011) PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma. Br J Dermatol 164: 141-7.
61. Sellheyer K, Nelson P (2011) Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens. J Cutan Pathol 38: 542-50.
62. Shaker A, Rubin DC (2010) Intestinal stem cells and epithelial- mesenchymal interactions in the crypt and stem cell niche. Transl Res 156: 180-7.
63. Simons BD, Clevers H (2011) Stem cell self-renewal in intestinal crypt. Exp Cell Res 317: 2719-24.
64. Sipos F, Valcz G, Molnar B (2012) Physiological and pathological role of local and immigrating colonic stem cells. World J Gastroenterol 18: 295-301.
65. Snippert HJ, van der Flier LG, Sato T, van Es JH, van den Born M, Kroon-Veenboer C, BarkerN, Klein AM, van Rheenen J, Simons BD, Clevers H (2010) Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143: 134-44.
66. Stange DE, Engel F, Longerich T, Koo BK, Koch M, Delhomme N, Aigner M, Toedt G, Schirmacher P, Lichter P, Weitz J, Radlwimmer B (2010) Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer livermetastases with 11p15.5 gain. Gut 59: 1236-44.
67. Stutz MA, Shattuck DL, Laederich MB, Carraway KL III, Sweeney C (2008) LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII. Oncogene 27: 5741-52.
68. Sureban SM,May R, Lightfoot SA,Hoskins AB, Lerner M, Brackett DJ, Postier RG, Ramanujam R, Mohammed A, Rao CV, Wyche JH, Anant S, Houchen CW (2011) DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism. Cancer Res 71: 2328-38.
69. TakedaN, Jain R, LeBoeuf MR,Wang Q, Lu MM, Epstein JA (2011) Interconversion between intestinal stem cell populations in distinct niches. Science 334: 1420-4.
70. Tang DG (2012) Understanding cancer stem cell heterogeneity and plasticity. Cell Res 22: 457-72.
71. Tateishi K, Ohta M, Kanai F, Guleng B, Tanaka Y, Asaoka Y, Tada M, Seto M, Jazag A, Lianjie L, Okamoto M, Isayama H, Yoshida H, Kawabe T, Omata M (2006) Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract. Clin Cancer Res 12: 6960-6.
72. Tian H, Biehs B, Warming S, Leong KG, Rangell L, Klein OD, de Sauvage FJ (2011) A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 478: 255-9.
73. Todaro M, Francipane MG, Medema JP, Stassi G (2010) Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138: 2151-62.
74. Umar S (2010) Intestinal stem cells. Curr Gastroenterol Rep 12: 340-8.
75. van der Flier LG, Clevers H (2009) Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 71: 241-60.
76. van der Flier LG, Haegebarth A, Stange DE, van de Wetering M, Clevers H (2009a) OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 137: 15-7.
77. van der Flier LG, van Gijn ME, Hatzis P, Kujala P, Haegebarth A, Stange DE, Begthel H, van den Born M, Guryev V, Oving I, van Es JH, Barker N, Peters PJ, van de Wetering M, Clevers H (2009b) Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 136: 903-12.
78. van Es JH, de Geest N, van de Born M, Clevers H, Hassan BA (2010) Intestinal stem cells lacking the Math1 tumour suppressor are refractory to Notch inhibitors. Nat Commun 1: 18.
79. Visvader JE (2011) Cells of origin in cancer. Nature 469: 314-22.
80. von Furstenberg RJ, Gulati AS, Baxi A, Doherty JM, Stappenbeck TS, Gracz AD, Magness ST, Henning SJ (2011) Sorting mouse jejunal epithelial cells with CD24 yields a population with characteristics of intestinal stem cells. Am J Physiol Gastrointest Liver Physiol 300: G409-17.
81. Walker F, Zhang HH, Odorizzi A, Burgess AW (2011) LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines. PLoS ONE 6: e22733.
82. Wang YK, Zhu YL, Qiu FM, Zhang T, Chen ZG, Zheng S, Huang J (2010) Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133{thorn} primary colon cancer cells. Carcinogenesis 31: 1376-80.
83. Wong MH (2004) Regulation of intestinal stem cells. J Investig Dermatol Symp Proc 9: 224-8.
84. Wong VW, Stange DE, Page ME, Buczacki S,Wabik A, Itami S, van de Wetering M, Poulsom R, Wright NA, Trotter MW, Watt FM, Winton DJ, Clevers H, Jensen KB (2012) Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. Nat Cell Biol 14: 401-8.
85. Yamaguchi S, Asanoma K, Takao T, Kato K, Wake N (2009) Homeobox gene HOPX is epigenetically silenced in human uterine endometrial cancer and suppresses estrogen-stimulated proliferation of cancer cells by inhibiting serum response factor. Int J Cancer 124: 2577-88.
86. Yan KS, Chia LA, Li X, Ootani A, Su J, Lee JY, Su N, Luo Y, Heilshorn SC, Amieva MR, Sangiorgi E, Capecchi MR, Kuo CJ (2012) The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc Natl Acad Sci USA 109: 466-71.
87. Yeung TM, Chia LA, Kosinski CM, Kuo CJ (2011) Regulation of self-renewal and differentiation by the intestinal stem cell niche. Cell Mol Life Sci 68: 2513-23.
88. Zeki SS, Graham TA, Wright NA (2011) Stem cells and their implications for colorectal cancer. Nat Rev Gastroenterol Hepatol 8: 90-100.
89. Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT, Poppleton H, Zakharenko S, Ellison DW, Gilbertson RJ (2009) Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457: 603-7.
90. Zhu R, Yang Y, Tian Y, Bai J, Zhang X, Li X, Peng Z, He Y, Chen L, Pan Q, Fang D, Chen W, Qian C, Bian X, Wang R (2012) Ascl2 knockdown results in tumor growth arrest by miRNA-302brelated inhibition of colon cancer progenitor cells. PLoS ONE 7: e32170.